Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +32.72%
#3 Fabric Protocol Fabric Protocol +23.80%
#4 Cysic Cysic +20.00%
#5 Nockchain Nockchain +19.55%
#6 Bedrock Bedrock +17.90%
#7 Epic Chain Epic Chain +12.10%
#8 Perle Perle +11.39%
#9 FOLKS FOLKS +8.38%
#10 The Black Bull The Black Bull +8.04%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
AOTI, Inc. AOTI, Inc.

AOTI, Inc.

AOTI
Rank in Stocks #37789
AOTI, Inc. specializes in creating and marketing healthcare technologies... AOTI, Inc. specializes in creating and marketing healthcare technologies specifically designed for treating persistent and hard-to-heal wounds. Among its offerings are the innovative Topical Wound Oxygen (TWO2) Therapy and the NEXA Negative Pressure Wound Therapy (NPWT) System. Michael Stephen Griffiths founded the company in 2006, and its main office is located in Oceanside, California.
Share Price
$1.36
Last synced: 2026-08-14
Market Cap
$1.45M
Change (1 day)
2.56%
Change (1 year)
70.12%
Country
US
Trade AOTI, Inc. (AOTI)

Category

Healthcare
Number of shares outstanding for AOTI, Inc. (AOTI)
Number of shares outstanding as of August 2026: 0
According to AOTI, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AOTI, Inc. (AOTI) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 1.74B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 383.50M -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 1.28B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 1.48B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 576.40M -
US